Chinese giant Wanhua Chemical Group, one of the largest chemical producers globally, has once again postponed the launch of its new cracking unit in Yantai. The plant is now expected to begin operations no earlier than late March to early April of this year. This development has drawn considerable attention within the chemical and energy…

The inauguration of a new president is always an event that sparks numerous forecasts and expectations, particularly within financial markets. This was certainly the case on January 20, when Donald Trump officially took office as the 45th president of the United States. This period was marked by a rise in key U.S. stock indices, which…

The inauguration of Donald Trump on Monday, January 20, 2025, has generated significant interest among politicians and the investment community. While Trump is unlikely to delve into the details of his political agenda during the event, his speech, coinciding with the historical federal holiday of Martin Luther King Jr. Day, could have a substantial impact…

The largest U.S. banks are reporting impressive profit growth despite the challenges facing the global economy. This trend has become particularly noticeable as the political era of Joe Biden comes to an end, with signs of market stability and recovery emerging after the pandemic crisis. Increased revenues from trading activities, a rise in the number…

Germany’s economy, the largest in the Eurozone, is once again facing significant challenges. According to the legal firm Weil, Gotshal & Manges LLP, Germany is considered the most troubled market in Europe for the second consecutive year. Despite some easing of pressure across Europe, the situation in Germany continues to deteriorate and could exceed levels…

The global economic climate has prompted many nations to reassess their currency management strategies. China, under pressure from external economic forces, has announced plans to take extensive action to slow the depreciation of the yuan. This decision comes in response to several challenges, including US tariffs and the strengthening of the dollar. Causes of Pressure…

In recent years, the world has been witnessing a rapid development of technologies, and one of the most notable companies in this field is Nvidia Corp. Renowned for its graphics processors and data processing chips, Nvidia has recently announced steps that could significantly alter the landscape of the artificial intelligence (AI) industry. Amidst the growing…

The year 2024 will be remembered in the investment community for significant shifts in the ranking of the most popular stocks. One of the biggest stories this year has been Nvidia’s rise to the top. According to Vanda Research, net retail investor investments in Nvidia stock reached an impressive nearly $30 billion. This surge has…

Amid the ongoing rise in cryptocurrency popularity, Tom Lee, co-founder of the analytical firm Fundstrat, has made a bold prediction for the leading digital asset. According to him, Bitcoin could climb to an impressive $250,000 by 2025. This forecast is backed by expectations of a more crypto-friendly regulatory environment, which could encourage investors to embrace…

On the global financial stage, tech giant Apple continues its remarkable dominance. As of the latest market close, the company’s market capitalization has soared to approximately $3.85 trillion. This staggering number cements Apple’s position as the world’s most valuable publicly traded company, with its valuation surpassing the combined stock market value of two major European…

Modern technologies and artificial intelligence continue to gain momentum, with new startups attracting significant investments. One such startup is xAI, founded by renowned entrepreneur Elon Musk. On Monday, it was announced that xAI raised $6 billion in Series C funding, highlighting a high level of investor confidence in the project. Funding participants and company valuation…

Novo Nordisk A/S, a globally renowned leader in the pharmaceutical industry and a key player in the weight-loss treatment segment, is facing a significant challenge. The company saw its stock price fall to record lows after clinical trial results revealed that patients using its experimental obesity drug, CagriSema, lost less weight than anticipated. This has…